Insider screener

Period: 12 months Role: 10% owners × Plan: Scheduled (10b5-1) × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

770 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

770 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

770 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

770 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
770 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
770 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

770 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
29 Oct 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$208.07K 134,240 at 1.55
2.0%
Planned (10b5-1)
29 Oct 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$208.07K 134,240 at 1.55
2.0%
Planned (10b5-1)
29 Oct 2025
Sold on a plan
$34.75K 25,000 at 1.39
14.3%
Planned (10b5-1)
29 Oct 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$649.00 100 at 6.49
0.0%
Planned (10b5-1)
28 Oct 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$159.01K 24,453 at 6.50
0.2%
Planned (10b5-1)
28 Oct 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$113.27K 69,068 at 1.64
1.0%
Planned (10b5-1)
28 Oct 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$113.27K 69,068 at 1.64
1.0%
Planned (10b5-1)
28 Oct 2025
Sold on a plan
$34.50K 25,000 at 1.38
12.5%
Planned (10b5-1)
27 Oct 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$401.59K 66,403 at 6.05
0.5%
Planned (10b5-1)
27 Oct 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$125.06K 72,709 at 1.72
1.1%
Planned (10b5-1)
27 Oct 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$125.06K 72,709 at 1.72
1.1%
Planned (10b5-1)
24 Oct 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$278.28K 46,696 at 5.96
0.3%
Planned (10b5-1)
23 Oct 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$924.72K 154,383 at 5.99
1.0%
Planned (10b5-1)
22 Oct 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$887.65K 144,266 at 6.15
1.0%
Planned (10b5-1)
22 Oct 2025
Sold on a plan
$31.00K 25,000 at 1.24
11.1%
Planned (10b5-1)
21 Oct 2025
Sold on a plan 2×
$2.11M 23,966 at 87.92
0.4%
Planned (10b5-1)
21 Oct 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$690.97K 109,675 at 6.30
0.7%
Planned (10b5-1)
21 Oct 2025
Sold on a plan
$36.25K 25,000 at 1.45
10.0%
Planned (10b5-1)
20 Oct 2025
Sold on a plan 3×
$2.07M 23,642 at 87.70
0.3%
Planned (10b5-1)
20 Oct 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$1.37M 220,535 at 6.20
1.4%
Planned (10b5-1)
Showing 751–770 of 770. ← Newer Page 16 of 16